盛永建

盛永建 (board member) discloses dealings in 三力制药 to SSE / SZSE (CSRC). Between 25 January 2022 and 22 May 2023, the trades on record add up to 5 filings.

Sales make up the whole of the open-market record (5 sales, €9.4M). 2023 to date brings no purchases and 3 sales.

The newest entry dates from 22 May 2023: an open-market sale of €1.5M, in 三力制药. The median gap between trade and publication is zero days: most filings appear on the same day. This delay matters because a trade only becomes useful information once it is public. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.